These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9452346)

  • 1. Posey and Spiller and progressive supranuclear palsy: an incorrect attribution.
    Siderowf AD; Galetta SL; Hurtig HI; Liu GT
    Mov Disord; 1998 Jan; 13(1):170-4. PubMed ID: 9452346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical perspectives and memories of progressive supranuclear palsy.
    Steele JC
    Semin Neurol; 2014 Apr; 34(2):121-8. PubMed ID: 24963672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): a short historical review.
    Pearce JM
    Neurologist; 2007 Sep; 13(5):302-4. PubMed ID: 17848869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: J. Clifford Richardson and 50 years of progressive supranuclear palsy.
    Weiner WJ
    Neurology; 2009 Jan; 72(2):199; author reply 199-200. PubMed ID: 19139374
    [No Abstract]   [Full Text] [Related]  

  • 5. J. Clifford Richardson and 50 years of progressive supranuclear palsy.
    Williams DR; Lees AJ; Wherrett JR; Steele JC
    Neurology; 2008 Feb; 70(7):566-73. PubMed ID: 18268249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort.
    Kaasinen V; Kangassalo N; Gardberg M; Isotalo J; Karhu J; Parkkola R; Sonninen P
    Neurol Sci; 2015 Jul; 36(7):1251-3. PubMed ID: 25805708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of progressive supranuclear palsy with fibrillary gliosis of the midbrain and pontine reticular formation.
    Ishino H; Sasaki T; Yamashita K; Senô H; Kodaka H; Yoshinaga J; Ideshita H; Yamanaka T; Hikiji A
    Clin Neuropathol; 1987; 6(2):61-6. PubMed ID: 3594976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early photographic case of probable progressive supranuclear palsy.
    Goetz CG
    Mov Disord; 1996 Nov; 11(6):617-8. PubMed ID: 8914085
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case report of Weber's syndrome associated with supranuclear vertical gaze palsy caused by the ipsilateral thalamomesencephalic lesion].
    Takami T; Sakaguchi M; Murata K; Nakabayashi H; Nakagawa O; Kawasaki H
    No To Shinkei; 1993 May; 45(5):461-4. PubMed ID: 8343298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.
    Koga S; Josephs KA; Ogaki K; Labbé C; Uitti RJ; Graff-Radford N; van Gerpen JA; Cheshire WP; Aoki N; Rademakers R; Wszolek ZK; Ross OA; Dickson DW
    Mov Disord; 2016 May; 31(5):653-62. PubMed ID: 26841329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. J C Steele's reflections on progressive supranuclear palsy.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1995 Jun; 58(6):710. PubMed ID: 7608672
    [No Abstract]   [Full Text] [Related]  

  • 12. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifty years of progressive supranuclear palsy.
    Colosimo C; Bak TH; Bologna M; Berardelli A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):938-44. PubMed ID: 24013274
    [No Abstract]   [Full Text] [Related]  

  • 14. Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy.
    Owens E; Krecke K; Ahlskog JE; Fealey R; Hassan A; Josephs KA; Klassen B; Matsumoto J; Bower J
    Parkinsonism Relat Disord; 2016 Jul; 28():107-11. PubMed ID: 27160570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
    Sakurai K; Tokumaru AM; Shimoji K; Murayama S; Kanemaru K; Morimoto S; Aiba I; Nakagawa M; Ozawa Y; Shimohira M; Matsukawa N; Hashizume Y; Shibamoto Y
    Neuroradiology; 2017 May; 59(5):431-443. PubMed ID: 28386688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
    Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
    Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging measures predict progression in progressive supranuclear palsy.
    Whitwell JL; Xu J; Mandrekar J; Gunter JL; Jack CR; Josephs KA
    Mov Disord; 2012 Dec; 27(14):1801-4. PubMed ID: 22415715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy. Historical notes.
    Steele JC
    J Neural Transm Suppl; 1994; 42():3-14. PubMed ID: 7964694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy].
    Yukitake M; Takashima Y; Kurohara K; Matsui M; Kuroda Y
    Rinsho Shinkeigaku; 1996 Jul; 36(7):906-8. PubMed ID: 8952364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Neurol Sci; 2017 Jul; 378():153-157. PubMed ID: 28566154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.